| TI: An outbreak of multidrug-resistant tuberculosis involving HIV-infected patients of two hospitals in Milan, Italy
AU: Moro, M. L.; Gori, A.; Errante, I.; Infuso, A.; Franzetti, F.; Sodano, L.; Iemoli, E. | Pág. 1095 |
| TI: Association between HIV-1 infection and miscarriage: a retrospective study
AU: D'Ubaldo, C.; Pezzotti, P.; Rezza, G.; Branca, M.; Ippolito, G. | Pág. 1087 |
| TI: Comparative prevalence, incidence and short-term prognosis of cervical squamous intraepithelial lesions amongst HIV-positive and HIV-negative women
AU: Six, C.; Heard, I.; Bergeron, C.; Orth, G.; Poveda, J.-D.; Zagury, P.; Cesbron, P.; Crenn-Hebert, C.; Pradinaud, R.; Sob | Pág. 1047 |
| TI: Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV
AU: Pinkerton, S. D.; Holtgrave, D. R.; Bloom, F. R. | Pág. 1067 |
| TI: Chemokines and receptors in HIV encephalitis
AU: Sanders, V. J.; Pittman, C. A.; White, M. G.; Wang, G.; Wiley, C. A.; Achim, C. L. | Pág. 1021 |
| TI: Disease progression and survival following specific AIDS-defining conditions: a retrospective cohort study of 2048 HIV-infected persons in London
AU: Petruckevitch, A.; Del Amo, J.; Phillips, A. N.; Johnson, A. M.; Stephenson, J.; Desmond, N.; Hanscheid, T.; Low, N.; Ne | Pág. 1007 |
| TI: Effect of HIV constructs containing protease-reverse transcriptase fusion proteins on viral replication
AU: Cherry, E.; Morin, N.; Wainberg, M. A. | Pág. 967 |
| TI: Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients
AU: Jandourek, A.; Vaishampayan, J. K.; Vazquez, J. A. | Pág. 1033 |
| TI: Expression of the human herpesvirus 8-encoded viral macrophage inflammatory protein-1 gene in Kaposi's sarcoma lesions
AU: Stuerzl, M.; Ascherl, G.; Blasig, C.; Opalenik, S. R.; Ensoli, B.; Browning, P. J. | Pág. 1105 |
| TI: Haptoglobin polymorphism, iron metabolism and mortality in HIV infection
AU: Delanghe, J. R.; Langlois, M. R.; Boelaert, J. R.; Van Acker, J.; Van Wanzeele, E.; Van Der Groen, G.; Hemmer, R.; Verho | Pág. 1027 |
| TI: HIV-1 diversity in heterosexual population in Slovakia, Ukraine and the Czech Republic
AU: Mayer, V.; Apetrei, C.; Habekova, M.; Tchentsova, N.; Bruckova, M.; Klaskala, W.; Baum, M. K.; Brun-Vezinet, F.; Simon, | Pág. 1106 |
| TI: HIV-1 diversity in Romania
AU: Apetrei, C.; Necula, A.; Holm-Hansen, C.; Loussert-Ajaka, I.; Pandrea, I.; Cozmei, C.; Streinu-Cercel, A.; Pascu, F.-R.; | Pág. 1079 |
| TI: Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients
AU: Vignoli, M.; Stecca, B.; Furlini, G.; Re, M. C.; Mantovani, V.; Zauli, G.; Visani, G.; Colangeli, V.; La Placa, M. | Pág. 999 |
| TI: Is AIDS a floating point between HIV seroconversion and death? Insights from the Tricontinental Seroconverter Study
AU: Van Benthem, B. H. B.; Veugelers, P. J.; Cornelisse, P. G. A.; Strathdee, S. A.; Kaldor, J. M.; Page Shafer, K. A.; Cout | Pág. 1039 |
| TI: Naturally occurring decreased susceptibility of HIV-1 subtype G to protease inhibitors
AU: Descamps, D.; Apetrei, C.; Collin, G.; Damond, F.; Simon, F.; Brun-Vezinet, F. | Pág. 1109 |
| TI: Nevirapine-induced hepatitis treated with corticosteroids?
AU: Leitze, Z.; Nadeem, A.; Choudhary, A.; Saul, Z.; Roberts, I.; Manthous, C. A. | Pág. 1115 |
| TI: Population effects of preventive and therapeutic HIV vaccines in early- and late-stage epidemics
AU: Owens, D. K.; Edwards, D. M.; Shachter, R. D. | Pág. 1057 |
| TI: Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain
AU: Gomez-Cano, M.; Rubio, A.; Puig, T.; Perez-Olmeda, M.; Ruiz, L.; Soriano, V.; Pineda, J. A.; Zamora, L.; Xaus, N.; Clote | Pág. 1015 |
| TI: Protease inhibitors do not increase the CD4+ cell count in HIV-uninfected individuals
AU: Barker, E.; Kahn, I.; Fujimura, S.; Levy, J. A. | Pág. 1117 |
| TI: Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors
AU: Menzo, S.; Sampaolesi, R.; Vicenzi, E.; Santagostino, E.; Liuzzi, G.; Chirianni, A.; Piazza, M.; Cohen, O. J.; Bagnarell | Pág. 985 |
| TI: Synthetic full-length and truncated RANTES inhibit HIV-1 infection of primary macrophages
AU: Ylisastigui, L.; Vizzavona, J.; Drakopoulou, E.; Paindavoine, P.; Calvo, C.-F.; Parmentier, M.; Gluckman, J. C.; Vita, C | Pág. 977 |
| TI: The epidemiological evolution of HIV-1 subtypes B and E among heterosexuals and injecting drug users in Thailand, 1992-1997
AU: Limpakarnjanarat, K.; Ungchusak, K.; Mastro, T. D.; Young, N. L.; Likhityingvara, C.; Sangwonloy, O.; Weniger, B. G.; Pa | Pág. 1108 |
| TI: The role of a stromal cell-derived factor-1 chemokine gene variant in the clinical course of HIV-1 infection
AU: Van Rij, R. P.; Broersen, S.; Goudsmit, J.; Coutinho, R. A.; Schuitemaker, H. | Pág. F85 |
| TI: Therapeutic advantage of hydroxyurea and didanosine combination therapy in patients previously treated with zidovudine
AU: Foli, A.; Maserati, R.; Minoli, L.; Wainberg, M. A.; Gallo, R. C.; Lisziewicz, J.; Lori, F. | Pág. 1113 |
| TI: Two doses of PMPA protect newborn macaques against oral simian immunodeficiency virus infection
AU: Van Rompay, K. K. A.; Berardi, C. J.; Aguirre, N. L.; Bischofberger, N.; Lietman, P. S.; Pedersen, N. C.; Marthas, M. L. | Pág. F79 |
| TI: Upregulation of Fas ligand secretion in non-lymphopenic stages of HIV-1 infection
AU: Silvestris, F.; Camarda, G.; Cafforio, P.; Dammacco, F. | Pág. 1103 |
| TI: Virological failure and adherence to antiretroviral therapy in HIV-infected patients
AU: Rodriguez-Rosado, R.; Jimenez-Nacher, I.; Soriano, V.; Anton, P.; Gonzalez-Lahoz, J. | Pág. 1112 |
| TI: Virological treatment failure of highly active antiretroviral therapy in an unselected cohort of HIV-infected patients
AU: Bonfanti, P.; Capetti, A.; Di Mattei, P.; Niero, F.; Rizzardini, G. | Pág. 1111 |